<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Johnson &#038; Johnson ordered to pay $4.7bn in talcum powder claim	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/johnson-johnson-talcum-powder/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/johnson-johnson-talcum-powder/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Tue, 13 Oct 2020 14:25:34 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
	<item>
		<title>
		By: Johnson &#38; Johnson shares slide as vaccine trial put on hold - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/johnson-johnson-talcum-powder/#comment-16082</link>

		<dc:creator><![CDATA[Johnson &#38; Johnson shares slide as vaccine trial put on hold - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 13 Oct 2020 14:25:34 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=12811#comment-16082</guid>

					<description><![CDATA[[&#8230;] multinational medical and pharmaceutical firm Johnson &#038; Johnson (NYSE:JNJ) has seen its shares slip 1.50% on Tuesday afternoon after it announced that its [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] multinational medical and pharmaceutical firm Johnson &amp; Johnson (NYSE:JNJ) has seen its shares slip 1.50% on Tuesday afternoon after it announced that its [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
